135 related articles for article (PubMed ID: 2920949)
21. Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis?
Salazar OM; DePapp EW; Bonfiglio TA; Feldstein ML; Rubin P; Rudolph JH
Cancer; 1977 Jul; 40(1):119-30. PubMed ID: 880545
[TBL] [Abstract][Full Text] [Related]
22. Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy.
Robboy SJ; Bradley R
Obstet Gynecol; 1979 Sep; 54(3):269-77. PubMed ID: 471366
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study.
Samuel S; Mukherjee S; Ammannagari N; Pokuri VK; Kuvshinoff B; Groman A; LeVea CM; Iyer R
PLoS One; 2018; 13(6):e0198809. PubMed ID: 29889907
[TBL] [Abstract][Full Text] [Related]
24. [Histology and prognosis of endometrial carcinoma].
Sakamoto A; Hirai Y; Yamauchi K; Kitagawa T; Sugano H; Masubuchi K; Hasumi K
Gan No Rinsho; 1987 Dec; 33(15):1897-900. PubMed ID: 3430742
[TBL] [Abstract][Full Text] [Related]
25. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
Jacques SM; Lawrence WD
Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
[TBL] [Abstract][Full Text] [Related]
26. Endometrial papillary adenocarcinomas: two clinicopathological types.
Chen JL; Trost DC; Wilkinson EJ
Int J Gynecol Pathol; 1985; 4(4):279-88. PubMed ID: 4086157
[TBL] [Abstract][Full Text] [Related]
27. Endometrial cancer: evaluation of spread and follow-up one hundred eighty-nine patients with Stage I or Stage II disease.
Burrell MO; Franklin EW; Powell JL
Am J Obstet Gynecol; 1982 Sep; 144(2):181-5. PubMed ID: 7114127
[TBL] [Abstract][Full Text] [Related]
28. Recurrent stage I endometrial carcinoma: results of treatment and prognostic factors.
Mandell LR; Nori D; Hilaris B
Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1103-9. PubMed ID: 3997592
[TBL] [Abstract][Full Text] [Related]
29. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system.
Grigsby PW; Perez CA; Kuten A; Simpson JR; Garcia DM; Camel HM; Kao MS; Galakatos AE
Int J Radiat Oncol Biol Phys; 1992; 22(5):905-11. PubMed ID: 1555983
[TBL] [Abstract][Full Text] [Related]
30. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
Carcangiu ML; Chambers JT
Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma of the endometrium.
Cavanagh D; Marsden DE; Ruffolo EH
Obstet Gynecol Annu; 1984; 13():211-60. PubMed ID: 6371616
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of histological variants of adenosquamous carcinoma of the corpus uteri].
Smirnov OA
Vopr Onkol; 1984; 30(3):32-7. PubMed ID: 6710946
[TBL] [Abstract][Full Text] [Related]
33. A suggested modification to FIGO stage I endometrial cancer.
Aristizabal P; Graesslin O; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
Gynecol Oncol; 2014 May; 133(2):192-6. PubMed ID: 24631453
[TBL] [Abstract][Full Text] [Related]
34. A clinicopathologic study of endometrial carcinoma with special reference to new histological variants.
Sato Y; Ozaki M; Ueda G; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):1015-9. PubMed ID: 2991395
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of pathologic features and DNA analysis in endometrial carcinoma.
Symonds DA
Gynecol Oncol; 1990 Dec; 39(3):272-6. PubMed ID: 2258070
[TBL] [Abstract][Full Text] [Related]
36. [Clinical studies of 145 cases of endometrial carcinoma--analysis of prognostic factors, especially pathological types].
Fukuma K; Tohya T; Souda Y; Fuzisaki S; Maeyama M; Mimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1508-14. PubMed ID: 3772201
[TBL] [Abstract][Full Text] [Related]
37. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
38. Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma.
Connelly PJ; Alberhasky RC; Christopherson WM
Obstet Gynecol; 1982 May; 59(5):569-75. PubMed ID: 7070727
[TBL] [Abstract][Full Text] [Related]
39. Papillary carcinomas of the endometrium.
Ward BG; Wright RG; Free K
Gynecol Oncol; 1990 Dec; 39(3):347-51. PubMed ID: 2258082
[TBL] [Abstract][Full Text] [Related]
40. The effect of estrogen receptor status on survival in patients with endometrial cancer.
Martin JD; Hähnel R; McCartney AJ; Woodings TL
Am J Obstet Gynecol; 1983 Oct; 147(3):322-4. PubMed ID: 6624797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
